USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of European Biosimilars Market
Analysis of European Biosimilars Market
Huge Market Opportunity from Impending Patent Expiries of Blockbuster Biologics.
RELEASE DATE
20-Dec-2011
20-Dec-2011
REGION
Europe
Europe
Research Code: M770-01-00-00-00
SKU: HC01950-EU-MR_07103
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01950-EU-MR_07103
Description
The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments.
Table of Contents
Summary of European Biosimilars Market
- Executive Summary
Introduction to the Total Biosimilars Market
- Total Biosimilars Market Overview
- Forecast and Trends - Global Biosimilars Market
- Market Share and Competitive Analysis - Global Biosimilars Market
Introduction to European Biosimilars Market
- European Biosimilars Market Overview
- Challenges; Drivers and Restraints - European Biosimilars Market
- Forecast and Trends - European Biosimilars Market
- Demand Analysis - European Biosimilars Market
- Market Share and Competitive Analysis - European Biosimilars Market
- Regulatory Guidelines - European Biosimilars Market
European Erythropoietin Biosimilars Market
- European Erythropoietin Biosimilars Market Overview
- Forecast and Trends - European Erythropoietin Biosimilars Market
- Market Share and Competitive Analysis - European Erythropoietin Biosimilars Market
- Regulatory Guidelines - European Erythropoietin Biosimilars Market
European Granulocyte Colony Stimulating Factors Biosimilars Market
- European Granulocyte Colony Stimulating Factors Biosimilars Market Overview
- Forecast and Trends - European Granulocyte Colony Stimulating Factors Biosimilars Market
- Market Share and Competitive Analysis - European Granulocyte Colony Stimulating Factors Biosimilars Market
- Regulatory Guidelines - European Granulocyte Colony Stimulating Factors Biosimilars Market
European Human Growth Hormone Biosimilars Market
- European Human Growth Hormone Biosimilars Market Overview
- Forecast and Trends - European Human Growth Hormone Biosimilars Market
- Market Share and Competitive Analysis - European Human Growth Hormone Biosimilars Market
- Regulatory Guidelines - European Human Growth Hormone Biosimilars Market
European Monoclonal Antibodies Biosimilars Market
- European Monoclonal Antibodies Biosimilars Market Overview
- Market Analysis - European Monoclonal Antibodies Biosimilars Market
- Regulatory Guidelines - European Monoclonal Antibodies Biosimilars Market
European Insulin Biosimilars Market
- European Insulin Biosimilars Market Overview
- Market Analysis - European Insulin Biosimilars Market
- Regulatory Guidelines - European Insulin Biosimilars Market
European Interferon Biosimilars Market
- European Interferon Biosimilars Market Overview
- Market Analysis - European Interferon Biosimilars Market
- Regulatory Guidelines - European Interferon Biosimilars Market
Biosimilars Market - The United Kingdom
Biosimilars Market - Germany
Biosimilars Market - France
Biosimilars Market - Italy
Biosimilars Market - Spain
Biosimilars Market - Benelux
Biosimilars Market - Scandinavia
- The United Kingdom Biosimilars Market Overview
- Forecast and Trends - The United Kingdom Biosimilars Market
Products in the Biosimilars Market
Conclusions of the study and Strategic Recommendations for Market Participants
Popular Topics
The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Srinivas Sashidhar |
| Industries | Healthcare |
| WIP Number | M770-01-00-00-00 |
| Is Prebook | No |